Anti-infective mode of action of EPs 7630 at the molecular level

Area of Science:

• Immunology
• Pharmacology
• Microbiology

Background:

• EPs 7630, an extract from Pelargonium sidoides roots, is clinically effective for respiratory infections.
• In vitro studies suggest EPs 7630 activates the non-specific immune system.
• The precise cellular and molecular mechanisms of EPs 7630 remain incompletely understood.

Purpose of the Study:

• To investigate the cellular and molecular mechanisms underlying the therapeutic benefits of EPs 7630.
• To elucidate how EPs 7630 modulates immune responses against intracellular bacterial infections.

Main Methods:

• Bone marrow-derived macrophages (BMM phi) were infected with Listeria monocytogenes.
• Cells were treated with varying concentrations of EPs 7630.
• Nitric oxide (NO), cytokine (IL-1, IL-12, TNF-alpha) production, and surface marker expression (CD40, CD119) were analyzed using flow cytometry and ELISA.

Main Results:

• EPs 7630 treatment increased NO release and production of IL-1, IL-12, and TNF-alpha in infected macrophages.
• Expression of CD40 and CD119 surface markers was altered by EPs 7630 in a concentration-dependent manner.
• These effects were more pronounced in infected cells compared to non-infected cells and observed at an early time point (6 hours post-infection).

Conclusions:

• EPs 7630 triggers significant innate immune responses, including cytokine release and immune cell marker modulation.
• The study provides valuable insights into the anti-infective effects of EPs 7630 at the cellular level.
• The immune response pathways activated by EPs 7630 are complex and distinct from those of classical immunomodulators.